The coagulation system has gained much interest again as new anticoagulatory substances
have been introduced into clinical practice. Especially patients with renal failure are likely …

Page 1 The National Collaborating Centre for Chronic Conditions CHRONIC KIDNEY
DISEASE National clinical guideline for early identification and management in adults in …

Background Disorders of mineral metabolism, including secondary hyperparathyroidism, are
thought to contribute to extraskeletal (including vascular) calcification among patients with …

Patients with end-stage renal disease suffer from complex hemostatic disorders. Uremic
patients show a bleeding diathesis that is mainly due to abnormalities of primary …

Patients with end‐stage renal disease (ESRD) develop hemostatic disorders mainly in the
form of bleeding diatheses. Hemorrhage can occur at cutaneous, mucosal, or serosal sites …

Abstract Background: Platelet-derived microparticles (PMPs) are generally considered a
marker of platelet activation in cardiovascular disease. We studied the extent to which PMP …

The P2Y 12 receptor is a key player in platelet activation and represents an effective
pharmacological target for the inhibition of platelet aggregation and prevention of …

Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and
endothelial dysfunction in uremia. Background Several cardiovascular risk factors are …

Background and Purpose—Persons with early stages of chronic kidney disease, defined by
a decreased glomerular filtration rate (GFR), have an increased risk of cardiovascular …

A role of coagulation proteases in kidney disease beyond their function in normal
haemostasis and thrombosis has long been suspected, and studies performed in the past 15 …